NCT06920758View on ClinicalTrials.gov

A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Thinning Hair
Interventions
DIETARY_SUPPLEMENT

USPlus DERM Bioactive Fatty Acids 160 mg Softgels

"USPlus® DERM Bioactive Fatty Acids (160 mg) Ingredient List (Per Softgel)~Active: 100% Concentrated Lipidosterolic Extract of Saw Palmetto (Serenoa repens).~Shell: Bovine Gelatin, Glycerin, Water"

OTHER

Placebo softgel

"Placebo Ingredient List:~Palm oil Gelatin Glycerin Water Caramel color"

Trial Locations (1)

90266

Ablon Skin Institute and Research Center, Manhattan Beach

Sponsors
All Listed Sponsors
collaborator

U.S. Nutraceuticals, Inc. dba Valensa International

UNKNOWN

lead

Ablon Skin Institute Research Center

OTHER